4D Molecular Therapeutics: Intravitreal Gene Therapy: A New Era of Durable Treatment for Retinal Vascular Diseases with 4D-150

Location: Regency C
Date & Time:
Saturday, 6th September, 10:15 – 11:15 CEST
Chairperson(s): A. Khanani, USA, A. Loewenstein, ISRAEL, B. Kuppermann, USA, D. Pieramici, USA, G. Cheung, USA

Speakers:

Presentations:

A. Khanani, USA

10:15  Welcome and Introductions

G. Cheung, USA

10:21  Unmet Needs in Retinal Vascular Disease

B. Kuppermann, USA

10:29  Introduction to 4D-150

D. Pieramici, USA

10:41  Clinical Data Overview

A. Loewenstein, ISRAEL

10:53  4-FRONT Protocol

A. Khanani, USA

11:01  The Future of 4D-150 for DME

A. Khanani, USA

11:09  Panel Discussion

Back to Main Programme